NO20031525L - Kjemokinmutanter i behandlingen av multippel sklerose - Google Patents
Kjemokinmutanter i behandlingen av multippel skleroseInfo
- Publication number
- NO20031525L NO20031525L NO20031525A NO20031525A NO20031525L NO 20031525 L NO20031525 L NO 20031525L NO 20031525 A NO20031525 A NO 20031525A NO 20031525 A NO20031525 A NO 20031525A NO 20031525 L NO20031525 L NO 20031525L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- multiple sclerosis
- chemokine mutants
- chemokine
- mutants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121665 | 2000-10-04 | ||
PCT/EP2001/011428 WO2002028419A2 (en) | 2000-10-04 | 2001-10-03 | Chemokine mutants in the treatment of multiple sclerosis |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20031525L true NO20031525L (no) | 2003-04-03 |
NO20031525D0 NO20031525D0 (no) | 2003-04-03 |
NO330278B1 NO330278B1 (no) | 2011-03-21 |
Family
ID=8170011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031525A NO330278B1 (no) | 2000-10-04 | 2003-04-03 | Anvendelse av en CC-kjemokinmutant i fremstillingen av en farmasoytisk sammensetning til behandlingen av multippel sklerose og/eller andre demyelinerende sykdommer, farmasoytisk sammensetning omfattende mutantene, trunkert og mutert human RANTES og rekombinant fremgangsmate for fremstilling av samme,DNA-molekyl som koder for dette, ekspresjonsvektor som omfatter DNA-molekylet og vertscelle som omfatter ekspresjonsvektoren |
Country Status (31)
Country | Link |
---|---|
US (1) | US7402303B2 (no) |
EP (1) | EP1326628B1 (no) |
JP (1) | JP3908165B2 (no) |
KR (1) | KR100837898B1 (no) |
CN (1) | CN1285381C (no) |
AR (1) | AR030854A1 (no) |
AT (1) | ATE265222T1 (no) |
AU (2) | AU2002215919B2 (no) |
BG (1) | BG66137B1 (no) |
BR (1) | BR0114407A (no) |
CA (1) | CA2423616C (no) |
CZ (1) | CZ303409B6 (no) |
DE (1) | DE60103078T2 (no) |
DK (1) | DK1326628T3 (no) |
EA (1) | EA006137B1 (no) |
EE (1) | EE05174B1 (no) |
ES (1) | ES2217199T3 (no) |
HK (1) | HK1062811A1 (no) |
HR (1) | HRP20030215B1 (no) |
HU (1) | HUP0302194A3 (no) |
IL (2) | IL155178A0 (no) |
MX (1) | MXPA03003008A (no) |
NO (1) | NO330278B1 (no) |
PL (1) | PL204231B1 (no) |
PT (1) | PT1326628E (no) |
RS (1) | RS50738B (no) |
SI (1) | SI1326628T1 (no) |
SK (1) | SK287523B6 (no) |
UA (1) | UA77950C2 (no) |
WO (1) | WO2002028419A2 (no) |
ZA (1) | ZA200302315B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002358144B2 (en) | 2001-12-17 | 2008-10-02 | Laboratoires Serono Sa | Chemokine mutants acting as chemokine antagonists |
EP1494703B1 (en) * | 2002-04-04 | 2006-03-08 | Applied Research Systems ARS Holding N.V. | Chemokines mutants having improved oral bioavailability |
WO2004062688A2 (en) * | 2002-12-23 | 2004-07-29 | Applied Research Systems Ars Holding N.V. | Use of cc-chemokine mutants against liver diseases |
AU2004283910A1 (en) * | 2003-10-22 | 2005-05-06 | Laboratoires Serono Sa | Novel CXCL8 antagonists |
AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
EP1439191B1 (en) * | 2004-01-19 | 2006-04-05 | Ares Trading S.A. | Process for the purification of bacterially expressed proteins |
GB0412400D0 (en) * | 2004-06-03 | 2004-07-07 | Univ Newcastle | Treatment of inflammatory conditions |
EP1760110B1 (en) * | 2005-09-03 | 2011-11-02 | Samsung SDI Co., Ltd. | Polybenzoxazine-based compound, electrolyte membrane including the same, and fuel cell employing the electrolyte membrane |
GB0614755D0 (en) | 2006-07-25 | 2006-09-06 | Univ Geneve | Cytokine derivatives |
EP2185719B1 (en) | 2007-08-02 | 2013-11-13 | NovImmune SA | Anti-rantes antibodies and methods of use thereof |
EP2539354B1 (en) * | 2010-02-08 | 2017-04-05 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
US20210205412A1 (en) | 2018-05-28 | 2021-07-08 | Université De Genève | Methods of inhibiting cerebral inflammation |
WO2022093857A1 (en) * | 2020-10-26 | 2022-05-05 | City Of Hope | Oncolytic virus compositions and methods for the treatment of cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739103A (en) * | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
WO1998006751A1 (en) * | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Mcp-3, rantes and mip-1alpha receptor antagonists |
EP0906954A1 (en) * | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
JP4323094B2 (ja) * | 1997-12-23 | 2009-09-02 | フォンダジオーネ セントロ サン ラファエロ デル モンテ タボール | Rantes変異体およびその治療用途 |
JP2002535376A (ja) * | 1999-01-29 | 2002-10-22 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | Ccr1アンタゴニストを用いた脱髄性炎症性疾患の治療方法 |
-
2001
- 2001-03-10 UA UA2003044038A patent/UA77950C2/uk unknown
- 2001-10-03 PT PT01986265T patent/PT1326628E/pt unknown
- 2001-10-03 EP EP01986265A patent/EP1326628B1/en not_active Expired - Lifetime
- 2001-10-03 DE DE60103078T patent/DE60103078T2/de not_active Expired - Lifetime
- 2001-10-03 EE EEP200300139A patent/EE05174B1/xx not_active IP Right Cessation
- 2001-10-03 SI SI200130130T patent/SI1326628T1/xx unknown
- 2001-10-03 KR KR1020037004599A patent/KR100837898B1/ko not_active IP Right Cessation
- 2001-10-03 DK DK01986265T patent/DK1326628T3/da active
- 2001-10-03 US US10/398,457 patent/US7402303B2/en not_active Expired - Fee Related
- 2001-10-03 CA CA2423616A patent/CA2423616C/en not_active Expired - Fee Related
- 2001-10-03 HU HU0302194A patent/HUP0302194A3/hu unknown
- 2001-10-03 IL IL15517801A patent/IL155178A0/xx unknown
- 2001-10-03 ZA ZA200302315A patent/ZA200302315B/en unknown
- 2001-10-03 SK SK406-2003A patent/SK287523B6/sk not_active IP Right Cessation
- 2001-10-03 AU AU2002215919A patent/AU2002215919B2/en not_active Ceased
- 2001-10-03 EA EA200300439A patent/EA006137B1/ru not_active IP Right Cessation
- 2001-10-03 PL PL362350A patent/PL204231B1/pl not_active IP Right Cessation
- 2001-10-03 BR BR0114407-3A patent/BR0114407A/pt not_active IP Right Cessation
- 2001-10-03 RS YUP-257/03A patent/RS50738B/sr unknown
- 2001-10-03 CZ CZ20030947A patent/CZ303409B6/cs not_active IP Right Cessation
- 2001-10-03 JP JP2002532243A patent/JP3908165B2/ja not_active Expired - Fee Related
- 2001-10-03 CN CNB018199178A patent/CN1285381C/zh not_active Expired - Fee Related
- 2001-10-03 ES ES01986265T patent/ES2217199T3/es not_active Expired - Lifetime
- 2001-10-03 AU AU1591902A patent/AU1591902A/xx active Pending
- 2001-10-03 MX MXPA03003008A patent/MXPA03003008A/es active IP Right Grant
- 2001-10-03 WO PCT/EP2001/011428 patent/WO2002028419A2/en active IP Right Grant
- 2001-10-03 AT AT01986265T patent/ATE265222T1/de active
- 2001-10-04 AR ARP010104684A patent/AR030854A1/es unknown
-
2003
- 2003-03-20 HR HR20030215A patent/HRP20030215B1/xx not_active IP Right Cessation
- 2003-03-28 BG BG107685A patent/BG66137B1/bg unknown
- 2003-04-01 IL IL155178A patent/IL155178A/en not_active IP Right Cessation
- 2003-04-03 NO NO20031525A patent/NO330278B1/no not_active IP Right Cessation
-
2004
- 2004-08-02 HK HK04105657A patent/HK1062811A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
ZA983452B (en) | Substituted pyrrolopyridines useful in the treatment of inflammatory diseases. | |
AU2001259758A1 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
PL362984A1 (en) | Compounds useful in the treatment of inflammatory diseases | |
ZA983451B (en) | Substituted imidazoles useful in the treatment of inflammatory diseases. | |
PL348059A1 (en) | Compounds useful in the treatment of inflammatory diseases | |
FR2804864B1 (fr) | Extraits de residus issus de la fabrication du vin et leur utilisation en cosmetique ou pharmacologie | |
EE200200286A (et) | Uued aminopropüülfosfiinhapped ning nende kasutamine | |
MXPA02004770A (es) | Composiciones terapeuticas y metodos para su uso. | |
ID28997A (id) | Kedok sekali pakai, dan proses pembuatannya | |
PL366305A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors | |
NO20031525D0 (no) | Kjemokinmutanter i behandlingen av multippel sklerose | |
NO20006113D0 (no) | Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer | |
AU2001265186A1 (en) | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions | |
AU2002243363A1 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
HUP0400262A3 (en) | Glycopeptides, their preparation and use in the treatment of multiple sclerosis | |
CA96874S (en) | Set of flatware | |
NO20025964D0 (no) | Ny interferon for behandling av multippel sklerose | |
ID30458A (id) | Osanetan dalam pengobatan gangguan jiwa | |
AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
NO962503D0 (no) | Anvendelse av penoksyfyllin ved behandling av multippel sklerose | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
NO20030762D0 (no) | Forbedret spesifisitet i behandling av sykdommer | |
CA96875S (en) | Set of flatware | |
CA96876S (en) | Set of flatware |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
MM1K | Lapsed by not paying the annual fees |